Intended Use:

The AESKULISA Parvovirus B19 IgG is a qualitative and quantitative immunoassay for the demonstration of human IgG antibodies in serum or plasma directed against Parvovirus B19. The AESKULISA Parvovirus B19 IgG serves for confirmation of a contact with the pathogen and supports in immune status determination.

Recombinant Antigens:

Virus-like Particels (VLPs) composed of recombinant VP2 produced in baculovirus-infected insect cells

Native Antigens:

n.a.